Tower Research Capital (TRC)’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.51K | Sell |
17,724
-1,584
| -8% | -$581 | ﹤0.01% | 4106 |
|
|
2025
Q1 | $5K | Buy |
19,308
+1,581
| +9% | +$410 | ﹤0.01% | 4175 |
|
|
2024
Q4 | $9.98K | Buy |
17,727
+4,050
| +30% | +$2.28K | ﹤0.01% | 3852 |
|
|
2024
Q3 | $8.21K | Buy |
13,677
+2,677
| +24% | +$1.61K | ﹤0.01% | 3975 |
|
|
2024
Q2 | $29.7K | Buy |
11,000
+10,977
| +47,726% | +$29.6K | ﹤0.01% | 3496 |
|
|
2024
Q1 | $118 | Sell |
23
-15,007
| -100% | -$77K | ﹤0.01% | 5636 |
|
|
2023
Q4 | $8.07K | Sell |
15,030
-786
| -5% | -$422 | ﹤0.01% | 4548 |
|
|
2023
Q3 | $10.5K | Buy |
15,816
+15,716
| +15,716% | +$10.4K | ﹤0.01% | 4103 |
|
|
2023
Q2 | $152 | Buy |
+100
| New | +$152 | ﹤0.01% | 5745 |
|
|
2023
Q1 | – | Sell |
-842
| Closed | -$1K | – | 5914 |
|
|
2022
Q4 | $1K | Sell |
842
-6,125
| -88% | -$7.27K | ﹤0.01% | 5577 |
|
|
2022
Q3 | $8K | Buy |
6,967
+1,585
| +29% | +$1.82K | ﹤0.01% | 4774 |
|
|
2022
Q2 | $8K | Buy |
5,382
+3,327
| +162% | +$4.95K | ﹤0.01% | 4672 |
|
|
2022
Q1 | $5K | Buy |
2,055
+1,060
| +107% | +$2.58K | ﹤0.01% | 5040 |
|
|
2021
Q4 | $6K | Buy |
+995
| New | +$6K | ﹤0.01% | 5017 |
|